Publisher
Springer Science and Business Media LLC
Reference233 articles.
1. Kola, I. & Landis, J. Can the pharmaceutical industry reduce attrition rates? Nature Rev. Drug Discov. 3, 711–716 (2004).
2. Langley, C. K. et al. Volunteer studies in pain research—opportunities and challenges to replace animal experiments: the report and recommendations of a Focus on Alternatives workshop. Neuroimage 42, 467–473 (2008).
3. Hill, R. NK1 (substance P) receptor antagonists–why are they not analgesic in humans? Trends Pharmacol. Sci. 21, 244–246 (2000). An interesting 'post-mortem' analysis of the failure of NK1 receptor antagonists to show efficacy in humans despite strong preclinical evidence.
4. Wallace, M. S. et al. A randomized, double-blind, placebo-controlled trial of a glycine antagonist in neuropathic pain. Neurology 59, 1694–1700 (2002).
5. Wallace, M. S. et al. A multicenter, double-blind, randomized, placebo-controlled crossover evaluation of a short course of 4030W92 in patients with chronic neuropathic pain. J. Pain 2, 4227–4233 (2002).
Cited by
888 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献